Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome

Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome

Mesenchymal stromal cells (MSCs) possess profound immunomodulatory and regenerative properties that are of clinical use in numerous clinical indications with unmet medical need. Common sources of MSCs include among others, bone marrow (BM), fat, umbilical cord, and placenta-derived decidua stromal c...

Full description

Bibliographic Details
Main Authors: Olle Ringdén, Guido Moll, Britt Gustafsson, Behnam Sadeghi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Immunology
Subjects:
cellular therapy
mesenchymal stromal cells (MSCs)
immunomodulation
regeneration
hematopoietic engraftment
graft-versus host disease (GvHD)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.839844/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.839844/full

Similar Items